Expert Committees

The following are appointed, pan-Canadian expert committees composed of individuals from across Canada with specific expertise related to their committee’s mandate.  

These expert committees may deliver advice, guidance, or recommendations that inform drug and health technology decisions in health systems across Canada. These committees report to the President and CEO of Canada’s Drug Agency. Members are appointed by the President and CEO following a public call for nominations. Visit the following pages to access each committee’s terms of reference, conflict of interest guidelines, and code of conduct. An honorarium is paid to each member for their preparation and meeting time.

• Canadian Drug Expert Committee
• Formulary Management Expert Committee
• Health Technology Expert Review Panel
• pCODR Expert Review Committee